Ref: MHL/Sec&Legal/2022-23/63 | Date: October 13, 2022 |
To, | To, |
Head, Listing Compliance Department | Head, Listing Compliance Department, |
BSE Limited, | National Stock Exchange of India Limited |
Phiroze Jeejeebhoy Towers, | Exchange Plaza, Plot No. C/1. G Block, |
Dalal Street, Mumbai - 400 001. | Bandra - Kurla Complex, Bandra (East), |
Scrip Code: 542650 | Mumbai - 400051 |
Scrip Symbol: METROPOLIS |
Sub: Intimation of allotment of Equity shares under the Metropolis Healthcare Limited -Restrictive Stock Unit Plan, 2020
Ref: Pursuant to Regulation 30 and Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Dear Sir/ Madam,
This is to inform you that, with reference to the above mentioned subject, the Nomination and Remuneration Committee of the Board of the Directors of the Company, via circular resolution on October 13, 2022 inter alia:
- Approved the allotment of 6,043 (Six Thousand and Forty Three Only) Equity shares of Rs.2/- (Rupees Two Only) each at an exercise price of Rs. 2/- (Rupees Two Only) each aggregating to Rs. 12,086 (Twelve Thousand and Eighty Six Only) against the Restrictive Stock Units ("RSU") vested in and exercised by the employees of the Company under the MHL- Restrictive Stock Unit Plan, 2020.
Further, the said shares shall rank pari passu in all respects with the existing Equity shares of the Company.
In terms of Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015 the details of shares allotted as above are given in 'Annexure-I';
You are requested to kindly take the same on record.
Thanking you,
Yours faithfully
For Metropolis Healthcare Limited
Simmi Singh Bisht
Head - Legal and Secretarial
Membership No. A23360
BLOOD TESTS • DIAGNOSTICS • WELLNESS
Metropolis Healthcare Limited
Registered & Corporate Office: 250 D, Udyog Bhavan, Hind Cycle Marg, Worli, Mumbai - 400 030.
CIN: L73100MH2000PLC192798 Tel No.: 8422 801 801 Email: support@metropolisindia.com
Website: www.metropolisindia.com
Global Reference Laboratory: 4th Floor, Commercial Building-1A, Kohinoor Mall, Vidyavihar (W), Mumbai - 400 070.
'Annexure - I'
Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021:
Company Name and address of Registered Office | Metropolis Healthcare Limited |
Add: 250 D Udyog Bhavan Worli Mumbai - | |
400030, Maharashtra, India | |
Name of the Stock Exchanges on which the | BSE Limited ("BSE") |
Company's shares are listed | The National Stock Exchange of India Limited |
("NSE") | |
Filing date of the statement referred in regulation | May 23, 2021 |
10(b) of the SEBI (Share Based Employee | |
Benefits) Regulations, 2014 read with the SEBI | |
(Share Based Employee Benefits and Sweat | |
Equity) Regulations, 2021 with the recognized | |
Stock Exchange | |
Filing Number, if any | Application No: |
BSE - Case No.130335 | |
NSE - Application No.27089 | |
In-Principle Approval Letter: | |
BSE: DCS/FL/PB/ESOP-IP/1301/2021-22 dated | |
June 24, 2021 | |
NSE: NSE/LIST/27089 dated June 15, 2021 | |
Title of the Scheme pursuant to which shares are | Metropolis-Restrictive Stock Unit Plan, 2020 |
issued, if any | |
Kind of security to be listed | Equity Shares |
Par value of the shares | Re. 2/- per share |
Date of issue of shares | October 13, 2022 |
Number of shares issued | 6,043 |
Share Certificate No., if applicable | Not Applicable |
Distinctive number of the share, if applicable | 5,12,00,250 to 5,12,06,292 (both inclusive) |
ISIN Number of the shares if issued in Demat | INE112L01020 |
Exercise price per share | Rs. 2/- per share |
Premium per share | Nil |
Total Issued shares after this issue | 5,12,06,292 shares |
Total Issued share capital after this issue | Rs.10,24,12,584 |
Details of any lock-in on the shares | 50% of the Equity Shares allotted to each RSU |
holder, upon exercise of RSUs under MHL-RSU | |
Plan, 2020 shall be subject to Lock-In for a period | |
of 1 year from the date of the allotment; |
BLOOD TESTS • DIAGNOSTICS • WELLNESS
Metropolis Healthcare Limited
Registered & Corporate Office: 250 D, Udyog Bhavan, Hind Cycle Marg, Worli, Mumbai - 400 030.
CIN: L73100MH2000PLC192798 Tel No.: 8422 801 801 Email: support@metropolisindia.com
Website: www.metropolisindia.com
Global Reference Laboratory: 4th Floor, Commercial Building-1A, Kohinoor Mall, Vidyavihar (W), Mumbai - 400 070.
Date of expiry of lock-in | October 13, 2023 |
Whether shares identical in all respects to existing | All equity shares rank pari passu in all respects |
shares if not, when will they become identical? | with the existing Equity shares of the Company. |
Details of listing fees, if payable | Not applicable |
Relevant disclosures as per SEBI circular CIR/CFD/CMD/4/2015 dated September 9, 2015:
Options Vested | 59,499 | |
Time within which option may be exercised | Within a maximum period of 5 years from the date | |
of vesting of such options. | ||
Options exercised | 6,043 | |
Money realized by exercise of options | Rs. 12,086/- | |
The total number of shares arising as result of | 6,043 Equity Shares | |
exercise of option | ||
Options lapsed | 1,11,765 | |
Diluted earnings per share pursuant to issue of | Rs. 5.52/- per shares | |
equity shares on exercise of options | ||
Whether the scheme is in terms of SEBI (Share | Yes | |
Based Employee Benefits and Sweat Equity) | ||
Regulations, 2021 | ||
For Metropolis Healthcare Limited |
Simmi Singh Bisht
Head - Lead & Secretarial
Membership No. A23360
BLOOD TESTS • DIAGNOSTICS • WELLNESS
Metropolis Healthcare Limited
Registered & Corporate Office: 250 D, Udyog Bhavan, Hind Cycle Marg, Worli, Mumbai - 400 030.
CIN: L73100MH2000PLC192798 Tel No.: 8422 801 801 Email: support@metropolisindia.com
Website: www.metropolisindia.com
Global Reference Laboratory: 4th Floor, Commercial Building-1A, Kohinoor Mall, Vidyavihar (W), Mumbai - 400 070.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Metropolis Healthcare Ltd. published this content on 13 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 October 2022 16:21:05 UTC.